Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Mechanism LXR-α modulators(nuclear receptor subfamily 1 group H member 3 modulators), NR1H2 modulators(nuclear receptor subfamily 1 group H member 2 modulators) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest Phase- |
First Approval Date- |
Regulation- |
Molecular FormulaC65H78ClF3N6O10S |
InChIKeyAVWXVADQEYZTET-ZXZGEIHWSA-N |
CAS Registry- |